Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name PF-07799933
Trade Name
Synonyms PF07799933|PF 07799933|ARRY440|ARRY 440|ARRY-440
Drug Descriptions

PF-07799933 inhibits BRAF mutations, including class 1, 2, and 3 mutations, which potentially leads to decreased downstream Erk signaling and inhibition of tumor growth (PMID: 38691346).

DrugClasses BRAF Inhibitor 25
CAS Registry Number NA
NCIT ID C191953

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Binimetinib + PF-07799933 Binimetinib PF-07799933 4 1
Cetuximab + PF-07799933 Cetuximab PF-07799933 0 1
PF-07799544 + PF-07799933 PF-07799544 PF-07799933 0 1
PF-07799933 PF-07799933 9 1


Additional content available in CKB BOOST